Table 1.
Linear Variant | Sequence | Activity Retained?(Y/N) | Source |
---|---|---|---|
| |||
Syn-safencin | LSLIAAAGKETIRQYLKNEIKKKGRKAVIAW | Y | - |
Library Parent | AGKETIRQYLKNEIKKKGRKAVIAW | Y | - |
AS-48 49–69 | ESIKAYLKKECKKKGKRACIA | N | Jimenez et al, 2005 |
AS-48 11–10 | VAGTVLNVVEAGGWVTTIVSILTAVGSGGLSLLAAAGRESIKAYLKKEIKKKGKRAVIAWMAKEFGIPAA | Y | Montalban-Lopez et al, 2008 |
AS-48 43–27 | LAAAGRESIKAYLKKEIKKKGKRAVIAWMAKEFGIPAAVAGTVLNVVEAGGWVTT | Y | Montalban-Lopez et al, 2008 |
AS-48 42,43–10 | LLAAAGRESIKAYLKKEIKKKGKRAVIAWMAKEFGIPAA | Y | Montalban-Lopez et al, 2008 |
Note: W70 is highlighted in gold, M1 is highlighted in red, I59 and V67 are highlighted in blue, and unnatural cysteines are highlighted in orange. Y = linear variant retains antimicrobial activity. N = linear variant does not retain any antimicrobial activity